Plain-English translation of NCT06727162 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying whether contrast-enhanced ultrasound — a special imaging technique that uses sound waves to take detailed pictures of your neck — can accurately assess how well your lymph nodes are responding to neoadjuvant chemoimmunotherapy (chemotherapy and immunotherapy given before surgery). Researchers want to understand if this imaging method can help doctors decide whether you actually need neck surgery after your initial cancer treatment, or if the lymph nodes have responded well enough that surgery might not be necessary.
After chemotherapy and immunotherapy for head and neck cancer, doctors need to know whether the swollen lymph nodes in the neck have shrunk or disappeared. Currently, there isn't a reliable imaging method to determine this, so many patients may undergo unnecessary neck surgery. This trial aims to find out whether this special ultrasound technique can provide better, more accurate answers to help doctors make smarter treatment decisions.
You likely qualify if…
You likely don't qualify if…
You will undergo contrast-enhanced ultrasound imaging of your neck, which involves receiving an injection of contrast material (a safe tracer) and then having ultrasound scans performed to visualize your lymph nodes in detail. This imaging will take place as part of your regular preoperative evaluation before your surgery. The ultrasound results will be compared with what happens during your surgery to help researchers understand how accurate this imaging technique is at predicting whether lymph nodes have responded to treatment.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
China